INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2013

Elevated phosphate levels are associated with vascular calcification, cardiovascular changes, and increased mortality.

Evidence from in vitro, clinical, and epidemiological studies indicates that elevated phosphate is associated with vascular calcification and mortality. High phosphate is linked to vessel wall thickness, arterial stiffness, and coronary calcification in children on dialysis, as well as mortality in adult dialysis patients. These cardiovascular changes are also observed in pre-dialysis CKD and in subjects with normal renal function who have high phosphate. Phosphate binders reduce serum phosphate, a decrease linked to improved survival, while raised phosphate triggers FGF-23, which may also act as an independent cardiovascular risk factor.

Shows an association, not proof of cause and effect.

Study type
Narrative review
Who was studied
Patients with CKD, dialysis patients, and individuals with normal renal function
What was measured
Vascular calcification, cardiovascular changes, and mortality

THE PAPER

Phosphate is a vascular toxin.

Shroff R. Pediatr Nephrol, 2013.

PubMed 23161206 ↗DOI 10.1007/s00467-012-2347-x ↗

Heart & arteriesKidney healthHealthy aging & longevityBones & muscles

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.